APA (7th ed.) Citation

Child, F., Ortiz ‐ Romero, P., Alvarez, R., Bagot, M., Stadler, R., WeichENthal, M., . . . Zinzani, P. (2016). Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB- IVA mycosis fungoides/Sézary syndrome. British Journal of Dermatology, 175(1), 80. https://doi.org/10.1111/bjd.14427

Chicago Style (17th ed.) Citation

Child, F., et al. "Phase II Multicentre Trial of Oral Quisinostat, a Histone Deacetylase Inhibitor, in Patients with Previously Treated Stage IB- IVA Mycosis Fungoides/Sézary Syndrome." British Journal of Dermatology 175, no. 1 (2016): 80. https://doi.org/10.1111/bjd.14427.

MLA (9th ed.) Citation

Child, F., et al. "Phase II Multicentre Trial of Oral Quisinostat, a Histone Deacetylase Inhibitor, in Patients with Previously Treated Stage IB- IVA Mycosis Fungoides/Sézary Syndrome." British Journal of Dermatology, vol. 175, no. 1, 2016, p. 80, https://doi.org/10.1111/bjd.14427.